Geron Corp. (GERN) and Advanced Cell Technology, Inc. (ACTC.OB) Offering Hope to Paralysis and Stargardt’s Macular Dystrophy Patients
Earlier this month, a historic moment happened; human embryonic stem cells were used to treat a patient in Atlanta. Geron Corporation received the first United States Food and Drug Administration (“FDA”) license to use its stem cells and technology to treat a patient with a spinal cord injury at Shepard Center in Atlanta, Georgia to set precedent for what could be the beginning of the revolutionary, albeit controversial, age of stem cells as a therapeutic discipline. While details are still being kept undisclosed, Geron did state that “Shepherd Center is one of seven potential sites in the United States that…